Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of €116.83 billion as of July 15, 2025. Its market cap has increased by 45.86% in one year.

Market Cap

116.83B

Enterprise Value

130.75B

Revenue

26.59B

Ranking

n/a

PE Ratio

21.17

Stock Price

€93.81

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 116.83B, an increase of 59,974.87%. That is a compound annual growth rate of 21.04%.

Market Cap History

Date	Market Cap	% Change
Jul 15, 2025	116.83B	5.07%
Dec 31, 2024	111.19B	21.76%
Dec 29, 2023	91.32B	-9.36%
Dec 30, 2022	100.75B	25.80%
Dec 31, 2021	80.09B	34.14%
Dec 31, 2020	59.70B	-18.50%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Siemens Healthineers AG	51.36B
Merck KGaA	49.04B
Bayer Aktiengesellschaft	26.86B
Fresenius SE & Co. KGaA	23.62B
Sartorius Aktiengesellschaft	13.71B
Fresenius Medical Care AG	13.57B
Fielmann Group AG	4.90B
Carl Zeiss Meditec AG	4.56B

Market Cap Rankings